pharma news

News

Arrows on grey background pointing left and right

FDA relents and will review Moderna's flu shot

The FDA will start a review of Moderna's flu jab mRNA-1010, after refusing to accept the filing last week, with a new "regulatory approach."

News

FDA starts review of BMS's 'celmod' for multiple myeloma

Bristol Myers Squibb could be months away from bringing the first 'celmod' to market, as the FDA starts a review of iberdomide for multiple myeloma.

News

Number of UK biotech companies rising, says report

A report has found that the number of life sciences companies domiciled in the UK has grown by nearly a quarter in the last few years.

News

Novartis' oral BTK drug moves the needle in CINDU

Novartis is set to expand the label for its oral BTK inhibitor Rhapsido, keeping the drug on course to become one of its biggest-ever brands.

News

NICE backs first disease-modifying drug for ARG1 deficiency

Immedica's Loargys is poised to become the first NHS therapy for ultra-rare genetic disorder ARG1 deficiency that can alter the course of the disease.

News

NHS study will pick apart mental illness with data science

Volunteers with schizophrenia, bipolar, and depression will take part in an NHS study that will use genetic and health data to find new therapies.

FDA relents and will review Moderna's flu shot

FDA starts review of BMS's 'celmod' for multiple myeloma

Number of UK biotech companies rising, says report

Novartis' oral BTK drug moves the needle in CINDU

NICE backs first disease-modifying drug for ARG1 deficiency

NHS study will pick apart mental illness with data science

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks